| Date Filed | Type | Description |
| 06/16/2023 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
| 06/12/2023 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 3,599 shares
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 8,500 options to buy
@ $4.34, valued at
$36.9k
|
|
| 10/15/2021 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 8,500 options to buy
@ $10.03, valued at
$85.3k
|
|
| 08/27/2021 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 39,389 options to buy
@ $2.56, valued at
$100.8k
Granted 17,068 options to buy
@ $6.54, valued at
$111.6k
|
|
| 08/27/2021 |
3
| Sebelius Kathleen (Director) has filed a Form 3 on Humacyte, Inc. |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2020 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 420 shares
@ $0 |
|
| 09/17/2020 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 21,603 options to buy
@ $21.47, valued at
$463.8k
|
|
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 58,608 options to buy
@ $7.65, valued at
$448.4k
|
|
| 07/26/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 3,981 shares
@ $0 |
|
| 06/14/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $0 |
|
| 06/14/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Bought 100 shares
@ $8.95, valued at
$895
Bought 100 shares
@ $8.93, valued at
$893
Bought 300 shares
@ $8.92, valued at
$2.7k
Bought 4,500 shares
@ $8.96, valued at
$40.3k
|
|
| 06/06/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.38, valued at
$56.3k
Granted 3,000 restricted stock units
@ $0 |
|
| 03/06/2019 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 4,219 shares
@ $0 |
|
| 03/06/2019 |
3
| Sebelius Kathleen (Director) has filed a Form 3 on EXACT SCIENCES CORP |
| 09/04/2018 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 22,500 options to buy
@ $24.25, valued at
$545.6k
|
|
| 06/14/2018 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.95, valued at
$59.7k
Granted 3,000 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0 |
|
| 10/20/2017 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Myovant Sciences Ltd. |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/26/2016 |
3
| Sebelius Kathleen (Director) has filed a Form 3 on Myovant Sciences Ltd. |
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |